MPA & Vasculitis GuideANCA vasculitis, starting with MPA and kidney disease
Urgent symptoms: when to get help now

Call 911 (or your local emergency number) for severe or sudden trouble breathing, coughing up blood, or heavy or spurting bleeding from a dialysis access.

Contact your care team promptly for new visible blood in urine, much less urine than usual, rapidly worsening swelling, fever while taking immune-suppressing medicine, being unable to keep transplant medicines down, or cloudy peritoneal dialysis fluid.

Follow the emergency plan your treating center gave you. More on urgent symptoms

Glossary

Evidence reviewed Nov 2026 Runs only in your browser

An organizer, not medical advice. Your care team interprets results. Nothing you type is sent anywhere. Privacy details

60 terms

AAV (ANCA-associated vasculitis)
The group of diseases that includes MPA, GPA and EGPA.
Acute kidney injury
A sudden drop in kidney function over hours to days.
Alveolar hemorrhage
Bleeding into the tiny air sacs of the lungs. An emergency.
ANCA
Antineutrophil cytoplasmic antibodies: antibodies against proteins in a type of white blood cell. Linked to AAV.
Anemia
Fewer red blood cells than normal; can cause tiredness. Common in kidney disease.
Anti-GBM
An antibody against the kidney filter membrane; tested when kidney function falls fast or there is lung bleeding.
Anti-rejection medicine (immunosuppressant)
Medicine taken after a transplant to stop the immune system attacking the new kidney.
Azathioprine
An immune-suppressing medicine sometimes used to keep AAV in remission.
B cells
Immune cells that make antibodies. Rituximab removes them.
Biopsy
Taking a small tissue sample to look at under a microscope.
BK virus
A common virus that can harm a transplanted kidney when immunity is suppressed.
BVAS
Birmingham Vasculitis Activity Score: a scoring system doctors and researchers use to measure disease activity.
CAR T-cell therapy
An experimental treatment in which a person's immune cells are engineered and infused back to remove target cells.
Cell-free DNA (donor-derived)
Bits of donor DNA in the recipient's blood; higher levels can flag injury to a transplanted kidney.
Complement
A part of the immune system that helps cause inflammation; some new medicines block parts of it.
Conservative kidney care
Care focused on symptoms and quality of life without dialysis or transplant.
Creatinine
A waste product in blood; higher levels usually mean the kidneys are filtering less.
Crescents (crescentic)
Biopsy finding of scarring-prone cell build-up in kidney filters, a sign of severe inflammation.
Cyclophosphamide
A strong immune-suppressing medicine used to induce remission in severe AAV.
Deceased donor
A kidney donated after someone has died.
Dialysis
Treatment that cleans the blood when kidneys cannot. Hemodialysis or peritoneal dialysis.
DSA (donor-specific antibodies)
Antibodies against the donor kidney's tissue type; a rejection risk marker.
eGFR
Estimated glomerular filtration rate: a calculation estimating how well the kidneys filter.
EGPA
Eosinophilic granulomatosis with polyangiitis, another disease in the ANCA vasculitis family.
ESRD / kidney failure
Kidney function too low to sustain life without dialysis or a transplant.
Fistula
A connection between an artery and a vein in the arm, made by surgery, used for hemodialysis.
Glomerulonephritis
Inflammation of the kidney's tiny filters (glomeruli).
Glucocorticoids (steroids)
Medicines like prednisone that reduce inflammation quickly.
GPA
Granulomatosis with polyangiitis, another disease in the ANCA vasculitis family, often PR3-ANCA.
Graft
A transplanted organ; also a tube used to make a hemodialysis access.
Hazard ratio
How fast an event happened in one study group compared with another.
Hemodialysis
Dialysis that filters blood through a machine outside the body.
HLA
Tissue-type markers used to match donors and recipients.
Induction
The first, stronger phase of treatment to calm active inflammation.
Interstitial lung disease
Inflammation or scarring of lung tissue; can be associated with MPO-ANCA disease.
Living donor
A living person, often family or a friend, who donates a kidney.
Maintenance
The longer, gentler treatment phase that keeps vasculitis in remission.
MPA
Microscopic polyangiitis: an autoimmune inflammation of small blood vessels, often affecting the kidneys.
MPO
Myeloperoxidase, the protein targeted by MPO-ANCA; most people with MPA have MPO-ANCA.
Nephrologist
A kidney specialist doctor.
Neuropathy
Nerve damage causing numbness, tingling, pain or weakness.
Paired donation
A swap in which incompatible donor-recipient pairs exchange kidneys.
Pauci-immune
Biopsy term meaning few immune deposits are seen; typical of ANCA kidney disease.
Peritoneal dialysis (PD)
Dialysis using the lining of the belly, through a catheter, by hand or overnight cycler.
Peritonitis
Infection of the belly lining; a risk with PD. Cloudy fluid is a warning sign.
Plasma exchange
Removing and replacing the liquid part of blood; considered in selected severe cases.
Pneumocystis pneumonia (PJP)
A lung infection that can affect people on strong immune suppression; preventive medicine is often discussed.
PR3
Proteinase 3, the protein targeted by PR3-ANCA.
Proteinuria
Protein in urine; can signal kidney filter damage.
Recurrence
MPA coming back, including in a transplanted kidney.
Rejection
The immune system attacking a transplanted organ.
Relapse
Vasculitis becoming active again after remission.
Remission
No signs of active disease.
Rheumatologist
A specialist doctor in autoimmune and joint diseases, often leading vasculitis care.
Rituximab
An antibody medicine that removes B cells; used to induce and maintain remission in AAV.
Tacrolimus
A common anti-rejection medicine; blood levels are checked regularly.
Thrill
The buzzing vibration felt over a working fistula or graft.
UPCR
Urine protein-to-creatinine ratio: a measure of protein leaking into urine.
Urinalysis
A urine test checking for blood, protein and cells.
Vasculitis
Inflammation of blood vessels.

Definitions summarize the guidelines and patient sources used across this site.1,2,3,4

Sources

  1. KDIGO: KDIGO 2024 Clinical Practice Guideline for the Management of ANCA-Associated Vasculitis [doc ref 1]
  2. NIDDK (NIH): Chronic kidney disease tests and diagnosis
  3. NIDDK (NIH): Kidney failure: treatment comparison chart [doc ref 45]
  4. Vasculitis Foundation: Microscopic polyangiitis (MPA) [doc ref 7]

Links checked 15 November 2026. Full list: all sources.